Foreign, local firms fight for market share as number of overweight or obese adults could top 630 million by 2050, from 400 ...

Adimab, LLC, the global leader in the discovery and engineering of fully human monoclonal and multispecific antibodies, today announced that 11 new programs entered clinical trials in 2025. These 11 ...

A study on rabbits dosed with viper venom suggests that botulinum toxin may alleviate some effects of snakebite, possibly by ...

Fiscal policy is the dominant market driver into 2025–26, but liquidity momentum is fading, raising volatility and downside ...

Everything is better with bacon, including pork tenderloin! My Barbecue Bacon Wrapped Tenderloin is crisp on the outside and juicy on the inside. It’s brined in Heath Riles BBQ Pork Injection and ...

Eli Lilly (LLY) says its weight-loss pill is on track to be approved in the US, lagging behind Novo Nordisk (NVO). Eli Lilly ...

Ractigen Therapeutics is pleased to announce that the first patient has been dosed in the Phase II clinical trial of RAG-17, an innovative siRNA therapy targeting SOD1-mutated amyotrophic lateral ...

ElpasBio Holdings ("ElpasBio"), a leading clinical-stage biotechnology company focused on regenerative medicine, today announced that it has entered into a collaboration agreement with Fosun Kairos ...

Anthropic has announced a new tool that brings Claude Code’s advanced capabilities to less tech-savvy users, letting them ...

Years of Western sanctions over Tehran's nuclear programme, coupled with corruption and financial mismanagement by the state, ...

ESTEVE and TerSera Therapeutics LLC announced today that they have entered into an agreement in which ESTEVE will acquire ...

After a year of significant disruption at Novo Nordisk, the company's R&D chief has told Fierce Biotech that the deal-hungry ...